KIMBERLY THOMPSON: Open Payments
NPI 1114538204 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,350 in 82 payments from 12 companies in 2025. Trend: 2023 $321 · 2024 $1,301 · 2025 $1,350
Food & beverage: $1,350
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $436 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $287 |
| Alkermes, Inc. | 7 | $158 |
| Otsuka America Pharmaceutical, Inc. | 10 | $144 |
| Collegium Pharmaceutical, Inc. | 5 | $97 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Supernus Pharmaceuticals, Inc. | 3 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Sage Therapeutics, LLC | 1 | $22 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, REXULTI, Jornay PM, Auvelity, SPRAVATO, Qelbree.
Industry payments across KY — which companies pay providers there.
